Immo Pharma Pas: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Immo Pharma Pas
Largest movements
- Cash -€29,842
down €29,842 (-15.9%), from €187,335 to €157,493
mainly Contributions, distributions and other (-€34,893) and Net result for the year (-€14,718)
- Tangible fixed assets -€12,691
down €12,691 (-51.8%), from €24,507 to €11,816
of which Furniture and vehicles: -€12,294
- Deferred charges and accrued income +€3,476
up €3,476 (+514.6%), from €675 to €4,151
- Reserves -€34,893
down €34,893 (-17.7%), from €197,558 to €162,665
of which Distributable reserves: -€34,893
- Profit (loss) carried forward -€14,718
down €14,718 (-84.5%), from -€17,417 to -€32,135
- Other debts +€6,987
up €6,987 (+37401.6%), from €19 to €7,005
- Trade debts +€4,247
up €4,247 (+16271.6%), from €26 to €4,273
- Gross operating margin -€1,771
down €1,771, from €903 to -€868
- Financial charges -€50
down €50 (-10.2%), from €488 to €438
- Taxes -€19
down €19 (-8.6%), from €220 to €201
- Other operating charges +€14
up €14 (+2.8%), from €505 to €520
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €242,974 | €204,009 | -€38,965 | -16.0% |
| Fixed assets | 21/28 | €24,507 | €11,816 | -€12,691 | -51.8% |
| Tangible fixed assets | 22/27 | €24,507 | €11,816 | -€12,691 | -51.8% |
| Plant, machinery and equipment | 23 | €788 | €390 | -€398 | -50.5% |
| Furniture and vehicles | 24 | €23,720 | €11,426 | -€12,294 | -51.8% |
| Current assets | 29/58 | €218,467 | €192,194 | -€26,273 | -12.0% |
| Amounts receivable within one year | 40/41 | €30,457 | €30,549 | +€92 | +0.3% |
| Trade receivables | 40 | €1,029 | €1,069 | +€41 | +3.9% |
| Other amounts receivable | 41 | €29,429 | €29,480 | +€52 | +0.2% |
| Cash at bank and in hand | 54/58 | €187,335 | €157,493 | -€29,842 | -15.9% |
| Deferred charges and accrued income | 490/1 | €675 | €4,151 | +€3,476 | +514.6% |
| Total equity and liabilities | 10/49 | €242,974 | €204,009 | -€38,965 | -16.0% |
| Equity | 10/15 | €242,141 | €192,530 | -€49,611 | -20.5% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €197,558 | €162,665 | -€34,893 | -17.7% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Distributable reserves | 133 | €191,358 | €156,465 | -€34,893 | -18.2% |
| Profit (loss) carried forward | 14 | -€17,417 | -€32,135 | -€14,718 | -84.5% |
| Amounts payable | 17/49 | €833 | €11,479 | +€10,646 | +1277.8% |
| Amounts payable within one year | 42/48 | €833 | €11,479 | +€10,646 | +1277.8% |
| Trade debts | 44 | €26 | €4,273 | +€4,247 | +16271.6% |
| Suppliers | 440/4 | €26 | €4,273 | +€4,247 | +16271.6% |
| Taxes, remuneration and social security | 45 | €788 | €201 | -€588 | -74.5% |
| Taxes | 450/3 | €788 | €201 | -€588 | -74.5% |
| Other amounts payable | 47/48 | €19 | €7,005 | +€6,987 | +37401.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €12,691 | €12,691 | = | 0.0% |
| Other operating charges | 640/8 | €505 | €520 | +€14 | +2.8% |
| Gross operating margin | 9900 | €903 | -€868 | -€1,771 | |
| Operating profit (loss) | 9901 | -€12,294 | -€14,079 | -€1,785 | -14.5% |
| Financial income | 75/76B | - | €0 | +€0 | |
| Recurring financial income | 75 | - | €0 | +€0 | |
| Financial charges | 65/66B | €488 | €438 | -€50 | -10.2% |
| Recurring financial charges | 65 | €488 | €438 | -€50 | -10.2% |
| Profit (loss) for the period before taxes | 9903 | -€12,782 | -€14,517 | -€1,735 | -13.6% |
| Income taxes | 67/77 | €220 | €201 | -€19 | -8.6% |
| Profit (loss) for the period | 9904 | -€13,002 | -€14,718 | -€1,716 | -13.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€13,002 | -€14,718 | -€1,716 | -13.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.